Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Christof von Kalle and Leif Sander.
Christof von Kalle
Connection Strength
0.747
Leif Sander
  1. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
    View in: PubMed
    Score: 0.240
  2. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
    View in: PubMed
    Score: 0.222
  3. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis. 2021 08; 27(8):2174-2178.
    View in: PubMed
    Score: 0.059
  4. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
    View in: PubMed
    Score: 0.059
  5. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
    View in: PubMed
    Score: 0.056
  6. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020 08; 38(8):970-979.
    View in: PubMed
    Score: 0.056
  7. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst. 2020 07 22; 11(1):11-24.e4.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.